Endoscopic level V lymph node dissection via breast combined with oral approach for papillary thyroid cancer
10.3760/cma.j.cn.115807-20220510-00120
- VernacularTitle:经胸经口联合入路腔镜甲状腺癌V区淋巴结清扫的探索
- Author:
Yuanyuan WANG
1
;
Yezhe LUO
;
Guoyang WU
;
Chaolong YAN
;
Hong LI
Author Information
1. 郑州大学第一附属医院甲状腺外二科，郑州 450000
- Keywords:
Papillary thyroid cancer;
Endoscopic thyroidectomy;
Region V neck dissection
- From:
Chinese Journal of Endocrine Surgery
2022;16(5):565-567
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and feasibility of endoscopic level V lymph node dissection for thyroid cancer.Methods:Two cases undergoing level V lymph node dissection via breast combined with oral approach for papillary thyroid cancer in May. 2021 and Sep.2021 were retrospectively analyzed. The primary thyroid lesions and metastatic lymph nodes were diagnosed pathologically by fine needle aspiration before operation. The routine examination such as ultrasound, CT and laryngoscopy were completed before operation.Results:Both operations were successfully completed under endoscopy. In case 1, one lymph node was found in neck V region, and no metastatic lymph node was found. In case 2, 7 lymph nodes were found in cervical V region. No "shoulder syndrome" encompassing shoulder dysfunction and pain was found in either case.Conclusions:The study on the two cases reveals that level V dissection after the routine operation of endoscopic central and lateral neck dissection via breast combined with oral approach for papillary thyroid cancer is feasible and safe. More cases in further study were needed for to verify the finding.
